Baxter International Inc. BAX
Price
Full chart with drawing tools and indicators
Valuation and ratios (P/E, margins, market value)
Price charts and figures by TradingView, shown in a sealed box: it cannot read this page, but TradingView may count your visit. Prices can be delayed.
Results from SEC filings
| Revenue | $11.2B | +6% | FY ending Dec 31, 2025 |
|---|---|---|---|
| Gross profit | $3.4B | -15% | FY ending Dec 31, 2025 |
| Operating income | $-308.0M | -2300% | FY ending Dec 31, 2025 |
| Net income | $-957.0M | -47% | FY ending Dec 31, 2025 |
| Earnings per share | $-1.87 | -47% | FY ending Dec 31, 2025 |
| Research & development | $518.0M | -12% | FY ending Dec 31, 2025 |
| Cash from operations | $845.0M | -17% | FY ending Dec 31, 2025 |
| Share buybacks | $0 | FY ending Dec 31, 2024 | |
| Dividends paid | $348.0M | -41% | FY ending Dec 31, 2025 |
| Cash | $2.0B | +11% | FY ending Dec 31, 2025 |
| Long-term debt | $9.4B | -28% | FY ending Dec 31, 2025 |
| Shareholders' equity | $6.1B | -12% | FY ending Dec 31, 2025 |
Insider trades
Last 12 months: 0 open-market buys ($0) and 0 sales ($0) by officers, directors and big owners. These are exact: shares times the price each insider reported. Several sales by one person on one day are combined (average price).
Other insider moves (39): pay awards, option exercises, tax withholding, gifts
| Insider | Trade | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| Andrew P. HiderPresident and CEO, Director | Tax withholding | 54,276 | $25.70 | $1.4M | Sep 2, 2026 |
| Julie FosterPresident, Front Line Care | Tax withholding | 2,098 | $25.70 | $54K | Sep 2, 2026 |
| James TeaffPresident, CCS | Tax withholding | 750 | $25.48 | $19K | Sep 1, 2026 |
| James TeaffPresident, CCS | Tax withholding | 321 | $18.68 | $5,996 | Jun 2, 2026 |
| Steven P. WallacePresident, Adv. Surgery | Tax withholding | 153 | $18.68 | $2,858 | Jun 2, 2026 |
| Anita A ZielinskiSVP, Interim CFO, CAO & Cntrlr | Award | 13,426 | – | – | Jun 1, 2026 |
| David S. WilkesDirector | Award | 12,836 | – | – | May 5, 2026 |
| Amy Mcbride WendellDirector | Award | 12,836 | – | – | May 5, 2026 |
| Nancy M SchlichtingDirector | Award | 12,836 | – | – | May 5, 2026 |
| Patricia MorrisonDirector | Award | 12,836 | – | – | May 5, 2026 |
| David Brent ShaferDirector | Award | 12,836 | – | – | May 5, 2026 |
| Michael R. McdonnellDirector | Award | 12,836 | – | – | May 5, 2026 |
| Jeffrey A CraigDirector | Award | 12,836 | – | – | May 5, 2026 |
| William A. Ii AmpofoDirector | Award | 12,836 | – | – | May 5, 2026 |
| Reazur RasulEVP,Group Pres,Healthcare | Tax withholding | 12,674 | $17.69 | $224K | Mar 6, 2026 |
| Joel T. GradeEVP and CFO | Tax withholding | 8,153 | $17.69 | $144K | Mar 6, 2026 |
| David S. RosenbloomEVP and General Counsel | Tax withholding | 6,620 | $17.69 | $117K | Mar 6, 2026 |
| Maria Cecilia SorianoGroup Pres., ITT & Pharma. | Tax withholding | 2,848 | $17.69 | $50K | Mar 6, 2026 |
| Anita A ZielinskiSVP, CAO and Controller | Tax withholding | 1,932 | $17.69 | $34K | Mar 6, 2026 |
| Maria Cecilia SorianoGroup Pres., ITT & Pharma. | Tax withholding | 1,852 | $19.69 | $36K | Mar 2, 2026 |
| Reazur RasulEVP,Group Pres,Healthcare | Tax withholding | 1,614 | $19.69 | $32K | Mar 2, 2026 |
| David S. RosenbloomEVP and General Counsel | Tax withholding | 1,336 | $19.69 | $26K | Mar 2, 2026 |
| Andrew P. HiderPresident and CEO, Director | Award | 201,804 | – | – | Feb 27, 2026 |
| Cynthia CarlisleExecutive Vice President, CHRO | Award2 fills | 29,677 | – | – | Feb 27, 2026 |
| Maria Cecilia SorianoGroup Pres., ITT & Pharma. | Award | 23,742 | – | – | Feb 27, 2026 |
| David S. RosenbloomEVP and General Counsel | Award | 26,709 | – | – | Feb 27, 2026 |
| Joel T. GradeEVP and CFO | Award | 42,735 | – | – | Feb 27, 2026 |
| Anita A ZielinskiSVP, CAO and Controller | Award | 30,864 | – | – | Feb 27, 2026 |
| Michael R. McdonnellDirector | Award | 1,811 | – | – | Feb 13, 2026 |
| Joel T. GradeEVP and CFO | Tax withholding | 9,144 | $21.73 | $199K | Feb 9, 2026 |
| Reazur RasulEVP,Group Pres,Healthcare | Tax withholding | 5,770 | $21.73 | $125K | Feb 9, 2026 |
| David S. RosenbloomEVP and General Counsel | Tax withholding | 5,225 | $21.73 | $114K | Feb 9, 2026 |
| Maria Cecilia SorianoGroup Pres., ITT & Pharma. | Tax withholding | 918 | $21.73 | $20K | Feb 9, 2026 |
| Maria Cecilia SorianoGroup Pres., ITT & Pharma. | Award | 2,273 | – | – | Feb 9, 2026 |
| David S. RosenbloomEVP and General Counsel | Award | 17,055 | – | – | Feb 9, 2026 |
| Reazur RasulEVP,Group Pres,Healthcare | Award | 18,951 | – | – | Feb 9, 2026 |
| Joel T. GradeEVP and CFO | Award | 30,504 | – | – | Feb 9, 2026 |
| Jeanne K MasonEVP, Chief HR Officer | Tax withholding | 650 | $19.15 | $12K | Dec 12, 2025 |
| Joel T. GradeEVP and CFO | Tax withholding | 8,288 | $19.08 | $158K | Dec 1, 2025 |
Trades by members of Congress
2 members reported 4 buys and 3 sales since May 15, 2025. Amounts are legal ranges, not exact figures.
| Member | Trade | Amount | Traded | Reported | Owner |
|---|---|---|---|---|---|
| Lisa C. McClain R | Sold | $1,001–$15K | Oct 31, 2025 | Nov 21, 2025 | Spouse |
| Lisa C. McClain R | Bought | $1,001–$15K | Oct 30, 2025 | Nov 21, 2025 | Spouse |
| Lisa C. McClain R | Sold | $1,001–$15K | Oct 30, 2025 | Nov 21, 2025 | Spouse |
| Lisa C. McClain R | Bought | $1,001–$15K | Sep 25, 2025 | Oct 22, 2025 | Spouse |
| Lisa C. McClain R | Sold | $1,001–$15K | Aug 4, 2025 | Sep 12, 2025 | Spouse |
| Lisa C. McClain R | Bought | $1,001–$15K | Jul 22, 2025 | Aug 13, 2025 | Spouse |
| Robert P. Bresnahan, Jr. R | Bought | $1,001–$15K | May 15, 2025 | Jun 9, 2025 | Self |
Latest SEC filings
- News filing: Executive or board change, Public announcement (Reg FD) 8-K · Aug 19, 2026
- News filing: Signed a major agreement, Other news 8-K · Aug 18, 2026
- News filing: Executive or board change 8-K · Aug 4, 2026
- News filing: Other news 8-K · Aug 4, 2026
- Quarterly report 10-Q · Jul 30, 2026
- News filing: Quarterly results, Other news 8-K · Jul 30, 2026
- News filing: Public announcement (Reg FD) 8-K · Jul 14, 2026
- Insider plans to sell 144 · May 18, 2026
- News filing: Executive or board change, Bylaws or fiscal year changed, Shareholder vote results 8-K · May 8, 2026
- Quarterly report 10-Q · Apr 30, 2026
- News filing: Quarterly results, Other news 8-K · Apr 30, 2026
- Shareholder meeting proxy DEF 14A · Mar 23, 2026
- News filing: Public announcement (Reg FD) 8-K · Mar 19, 2026
- News filing: Executive or board change, Public announcement (Reg FD) 8-K · Mar 16, 2026
- Annual report 10-K · Feb 12, 2026
- News filing: Quarterly results, Executive or board change, Other news 8-K · Feb 12, 2026
- News filing: Other news 8-K · Dec 22, 2025
- News filing: Signed a major agreement, Ended a major agreement, Took on new debt, Other news 8-K · Dec 4, 2025
- News filing: Signed a major agreement 8-K · Nov 25, 2025
- News filing: Other news 8-K · Nov 19, 2025
- News filing: Other news 8-K · Nov 19, 2025
- News filing: Executive or board change 8-K · Nov 12, 2025
- Quarterly report 10-Q · Nov 4, 2025
- News filing: Quarterly results 8-K · Oct 30, 2025
- News filing: Executive or board change 8-K · Oct 21, 2025
About Baxter International Inc.
Business description
- Industry
- Surgical & Medical Instruments & Apparatus
- Sector
- Industrial Applications and Services
- Headquarters
- Deerfield, IL
- Incorporated in
- DE
- Fiscal year ends
- December 31
- Exchange
- NYSE
- Filer size
- Large accelerated filer
- SEC company number (CIK)
- 10456
Company figures and insider trades: U.S. Securities and Exchange Commission (EDGAR). Congress trades: Clerk of the U.S. House of Representatives. Nebula is not affiliated with either and this page is not investment advice.